A new study led by Carla Finkielstein, an associate professor at the Fralin Biomedical Research Institute at VTC, and Diego Golombek, a professor at the National University of Quilmes, reveals that chronic jet lag impedes the body’s immune system and also changes the tumor microenvironment, favoring tumor growth.
In first-of-their-kind observations in the human brain, an international team of researchers has revealed two well-known neurochemicals — dopamine and serotonin — are at work at sub-second speeds to shape how people perceive the world and take action based on their perception.
Ian Kimbrough, an assistant professor in the School of Neuroscience, and Jennifer Munson, an assistant professor in the Department of Biomedical Engineering and Mechanics, are taking research learned from brain tumors to help fight Alzheimer’s.
The finding gives scientists a path to understand diseases where frequent blood-brain barrier damage occurs, including traumatic brain injury, stroke, epilepsy, Alzheimer’s disease, and Parkinson’s disease.
Research expenditures are up and sponsored awards have increased by 15 percent, building upon the prior year’s expenditure total of $542 million, despite the impact of COVID-19 felt nationally by higher education institutes, according to preliminary fiscal year-end reports.
A multidisciplinary team is helping the university better understand and plan for impacts of COVID-19 through institution-specific models, outbreak simulations, and impact on regional hospital resources predictions.
Starting this week, as students begin to return to campus for the fall semester, the lab’s capacity of 1,000 tests per day will also be dedicated to Virginia Tech students and employees in high-contact roles.
Roanoke-based cancer research startup, Acomhal Research Inc., secured a $399,878 Small Business Technology Transfer grant to determine if a molecule that stalls the spread of invasive brain cancer stem cells can help treat aggressive forms of breast cancer.
Fralin Biomedical Research Institute scientists have revealed how a nonfunctioning version of an ordinary gene impairs brain structure and function. The findings help explain a genetic form of microcephaly — a condition where babies’ heads are small and grow more slowly than their peers' heads.
Research partners across three institutions are opening the nation’s first and only resource center, known as C-PROGRESS, dedicated to promoting clinical trials research in the rapidly expanding field of pediatric rehabilitation.
Supported by a new, five-year, $2.8 million National Institutes of Health grant awarded to Harald Sontheimer, a glial neurobiologist at the Fralin Biomedical Research Institute at VTC, scientists are probing changes caused by aging in the circulatory system in the normal brain and Alzheimer’s disease brain.
The brain’s ventral lateral geniculate nucleus receives signals from the eye, but it is not associated with classical image-forming. In a new study, Fralin Biomedical Research Institute at VTC neuroscientists reveal newly identified brain cell subtypes unique to this region that form a striking layered formation.
Finkielstein, a molecular biologist and an associate professor in the College of Science, will join the Fralin Biomedical Research Institute at VTC on July 1. Her laboratory, which studies how circadian rhythms are involved in breast cancer progression, will move to the Health Sciences and Technology Campus in Roanoke.
Anthony-Samuel LaMantia, a developmental neurobiologist and a professor at the Fralin Biomedical Research Institute at VTC, has been named the new director of the institute’s Center for Neurobiology Research, according to Michael Friedlander, executive director of the research institute and Virginia Tech vice president for health sciences and technology.
Fox, director of the Center for Neurobiology Research at the Fralin Biomedical Research Institute at VTC, will move from his current leadership position into a new role as director of the School of Neuroscience, taking over a position held by founding director Harald Sontheimer.
A dose of adenovirus hits most people like a common cold – a cough, a fever, maybe a sore throat. But for an unfortunate few, the usually benign bug hacks the heart’s cellular electrical communication system and sometimes proves fatal.